<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="several months or even years. The structural superposition of the" exact="hepatitis C" post="virus polymerase bound to sofosbuvir, a nucleoside analog antiviral"/>
 <result pre="polymerase bound to sofosbuvir, a nucleoside analog antiviral approved for" exact="hepatitis C" post="virus infections, with the SARS-CoV polymerase shows that the"/>
 <result pre="viruses, opening the possibility to use sofosbuvir against these highly" exact="infectious" post="pathogens. Subject terms Molecular medicine Virology Introduction A rapid"/>
 <result pre="A rapid response to a cluster of patients affected with" exact="pneumonia" post="of unknown cause in Wuhan, China in December 2019,"/>
 <result pre="and MERS-CoVs, which caused epidemics in 2002â€&quot;2003 and 2012, respectively." exact="Infections" post="by these viruses had higher mortality rates compared to"/>
 <result pre="zika in 2016, in addition to the endemic dengue and" exact="yellow fever" post="viral outbursts, which annually infect hundreds of thousands of"/>
 <result pre="2016, in addition to the endemic dengue and yellow fever" exact="viral" post="outbursts, which annually infect hundreds of thousands of patients"/>
 <result pre="annually infect hundreds of thousands of patients in tropical regions4." exact="Combined" post="with their high mutation rates, large population sizes and"/>
 <result pre="mutation rates, large population sizes and fast replicative cycles, RNA" exact="viral" post="populations quickly explore a vast number of mutational landscapes,"/>
 <result pre="mutational landscapes, which can lead to the emergence of new" exact="infectious" post="viruses in humans or viruses with different pathogenic properties."/>
 <result pre="antivirals available to treat the vast majority of emergent RNA" exact="viral" post="infections. This is due to the extreme variability of"/>
 <result pre="infections. This is due to the extreme variability of RNA" exact="viral" post="proteomes and the absence of conserved therapeutic targets at"/>
 <result pre="to the extreme variability of RNA viral proteomes and the" exact="absence of" post="conserved therapeutic targets at which antivirals could be aimed."/>
 <result pre="HIV-1 protease inhibitors Lopinavir/Ritonavir; Interferon Î²-1a; the anti-malarial hydroxychloroquine/chloroquine as" exact="viral" post="entry inhibitors, and viral RdRp inhibitor Remdesivir. Furthermore, over"/>
 <result pre="Interferon Î²-1a; the anti-malarial hydroxychloroquine/chloroquine as viral entry inhibitors, and" exact="viral" post="RdRp inhibitor Remdesivir. Furthermore, over 950 clinical trials worldwide"/>
 <result pre="highly conserved protein in all known RNA viruses is the" exact="viral" post="monomeric RdRp. The coronavirus replication machinery is a large"/>
 <result pre="palm subdomains, and the six conserved structural motifs (Fig.Â 1)7." exact="Structural" post="and phylogenetic analysis indicate that all known viral RdRps"/>
 <result pre="(Fig.Â 1)7. Structural and phylogenetic analysis indicate that all known" exact="viral" post="RdRps are monophyletic and preserve a high degree of"/>
 <result pre="site and that have been approved to treat other RNA" exact="viral" post="diseases, including Favipiravir9 and Remdesivir10. This latter is an"/>
 <result pre="which has been shown to be efficacious preventing different coronaviral" exact="infections" post="in mice, and viral populations lacking the ExoN activity"/>
 <result pre="to be efficacious preventing different coronaviral infections in mice, and" exact="viral" post="populations lacking the ExoN activity are more sensitive to"/>
 <result pre="drug11. Recently, this drug proved to be effective blocking SARS-CoV-2" exact="infection" post="in vitro12. Figure 1 Three-dimensional structure of the SARS-CoV"/>
 <result pre="the Betacoronavirus genus and structural superposition of SARS-Coronavirus nsp12 with" exact="hepatitis C" post="virus NS5B bound to Sofosbuvir. (a) Multiple alignment of"/>
 <result pre="nsp12 with hepatitis C virus NS5B bound to Sofosbuvir. (a)" exact="Multiple" post="alignment of SARS-CoV-2 nsp12 and other coronaviruses including SARS-CoV"/>
 <result pre="COVID-19 pandemic; nevertheless, the two latter aspects and previous RNA" exact="viral" post="infections suggest that a multitargeted approach, in which different"/>
 <result pre="pandemic; nevertheless, the two latter aspects and previous RNA viral" exact="infections" post="suggest that a multitargeted approach, in which different drugs"/>
 <result pre="that a multitargeted approach, in which different drugs target different" exact="viral" post="proteins, might be the ultimate strategy. From an evolutionary"/>
 <result pre="From an evolutionary perspective, the highly conserved palm subdomain of" exact="viral" post="RdRps might be the RNA viral Achilles heel. The"/>
 <result pre="conserved palm subdomain of viral RdRps might be the RNA" exact="viral" post="Achilles heel. The availability of additional tertiary structures can"/>
 <result pre="can help to understand the differences and the relatedness between" exact="viral" post="RdRps, which, in turn, may lead to more alternatives"/>
 <result pre="nsp12 multiple alignment From the orf1ab polyprotein (Wuhan seafood market" exact="pneumonia" post="virus isolate Wuhan-Hu-1) deposited in the NCBI (NC_045512.2), we"/>
 <result pre="residues corresponding to the conserved structural motifs A-F are shown." exact="Structural" post="superposition of hepatitis C virus and SARS-CoV polymerases The"/>
 <result pre="the conserved structural motifs A-F are shown. Structural superposition of" exact="hepatitis C" post="virus and SARS-CoV polymerases The structural superposition of the"/>
 <result pre="C virus and SARS-CoV polymerases The structural superposition of the" exact="hepatitis C" post="virus polymerase NS5B bound to Sofosbuvir [PDB ID: 4WTG13]"/>
 <result pre="interests The authors declare no competing interests. References References 1.HuiDSCZumlaASevere" exact="acute" post="respiratory syndrome: historical, epidemiological and clinical featuresInfect. Dis. Clin."/>
 <result pre="The authors declare no competing interests. References References 1.HuiDSCZumlaASevere acute" exact="respiratory" post="syndrome: historical, epidemiological and clinical featuresInfect. Dis. Clin. N."/>
 <result pre="and clinical featuresInfect. Dis. Clin. N. Am.20193386988910.1016/j.idc.2019.07.001 2.AsharEIHuiDSCMemishZAZumlaAThe Middle East" exact="respiratory" post="syndrome (MERS)Infect. Dis. Clin. N. Am.20193389190510.1016/j.idc.2019.08.001 3.WHO. Coronavirus disease"/>
 <result pre="clinical featuresInfect. Dis. Clin. N. Am.20193386988910.1016/j.idc.2019.07.001 2.AsharEIHuiDSCMemishZAZumlaAThe Middle East respiratory" exact="syndrome" post="(MERS)Infect. Dis. Clin. N. Am.20193389190510.1016/j.idc.2019.08.001 3.WHO. Coronavirus disease (COVID-19)"/>
 <result pre="East respiratory syndrome (MERS)Infect. Dis. Clin. N. Am.20193389190510.1016/j.idc.2019.08.001 3.WHO. Coronavirus" exact="disease" post="(COVID-19) Situation dashboard â€&quot; April 18th, 2020, https://covid19.who.int/ (2020)."/>
 <result pre="al.A yellow flag on the horizon: the looming threat of" exact="yellow fever" post="to North AmericaInt. J. Infect. Dis.20198714315010.1016/j.ijid.2019.07.03331382047 5.OgandoNSet al.The curious"/>
 <result pre="therapeutic implicationsPLoS ONE201510e013900110.1371/journal.pone.013900126397100 9.FurutaYKomenoTNakamuraTFavipiravir (T-705), a broad spectrum inhibitor of" exact="viral" post="RNA polymeraseProc. Jpn. Acad. Ser. B.20179344946310.2183/pjab.93.02728769016 10.WarrenTKet al.Therapeutic efficacy"/>
 <result pre="molecule GS-5734 against Ebola virus in Rhesus monkeysNature.201653138138510.1038/nature1718026934220 11.AgostiniMLet al.Coronavirus" exact="susceptibility to" post="the antiviral Remdesivir (GS-5734) is mediated by the viral"/>
 <result pre="susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the" exact="viral" post="polymerase and the proofreading exonucleasemBio.20189e002211810.1128/mBio.00221-1829511076 12.Wang, M. et al."/>
 <result pre="10.1038/s41422-020-0282-0 (2020) 13.ApplebyTCet al.Structural basis for RNA replication by the" exact="Hepatitis" post="C virus polymeraseScience.201534777177510.1126/science.125921025678663 14.GanCSLimSKCheeCFYusofRHehCHSofosbuvir as treatment against Dengue?Chem. Bio."/>
 <result pre="Clin. Transl. Hepatol.20153273510.14218/JCTH.2014.0004126357632 20.DonaldsonEFHarringtonPROâ€™RearJJNaegerLKClinical evidence and bioinformatics characterization of potential" exact="hepatitis C" post="virus resistance pathways for sofosbuvirHepatology201561566510.1002/hep.2737525123381 21.Clinton SmithEBlancHSurdelMCVignuzziMDenisonMRCoronaviruses lacking exoribonuclease"/>
</results>
